Therapies in Cervical Cancer-Editorial
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
George Papanikolaou is famously quoted as saying "the first observation of cancer cells in the smear of the uterine cervix gave me one of the greatest thrills I ever experienced during my scientific career" [...].
References
1.
Saha S, Rundle S, Kotsopoulos I, Begbie J, Howarth R, Pappworth I
. Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy. Cancers (Basel). 2022; 14(17).
PMC: 9454916.
DOI: 10.3390/cancers14174288.
View
2.
Muallem M, Armbrust R, Neymeyer J, Miranda A, Muallem J
. Nerve Sparing Radical Hysterectomy: Short-Term Oncologic, Surgical, and Functional Outcomes. Cancers (Basel). 2020; 12(2).
PMC: 7072686.
DOI: 10.3390/cancers12020483.
View
3.
Tomizawa K, Kaminuma T, Murata K, Noda S, Irie D, Kumazawa T
. FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era. Cancers (Basel). 2020; 12(7).
PMC: 7408064.
DOI: 10.3390/cancers12071770.
View
4.
Frelaut M, de Glas N, Zapardiel I, Kaidar-Person O, Kfoury M, You B
. Are Older Patients with Cervical Cancer Managed Differently to Younger Patients? An International Survey. Cancers (Basel). 2019; 11(12).
PMC: 6966543.
DOI: 10.3390/cancers11121955.
View
5.
Ponce J, Fernandez-Gonzalez S, Gil-Moreno A, Coronado P, de la Rosa J, Nabais H
. Risk Factors for Recurrence after Robot-Assisted Radical Hysterectomy for Early-Stage Cervical Cancer: A Multicenter Retrospective Study. Cancers (Basel). 2020; 12(11).
PMC: 7696424.
DOI: 10.3390/cancers12113387.
View